NTRA - Natera Inc Stock Price, Fair Value and News

95.12USD-2.03 (-2.09%)Delayed as of 08 May 2024, 01:34 pm ET

Market Summary

USD95.12-2.03

Delayedas of 08 May 2024, 01:34 pm

-2.09%

NTRA Alerts

4 major insider sales recently.

NTRA Stock Price

View Fullscreen

NTRA RSI Chart

NTRA Valuation

Market Cap

11.7B

Price/Earnings (Trailing)

-27

Price/Sales (Trailing)

10.84

EV/EBITDA

-27.9

Price/Free Cashflow

-41.03

NTRA Price/Sales (Trailing)

NTRA Profitability

EBT Margin

-40.14%

Return on Equity

-56.81%

Return on Assets

-30.16%

Free Cashflow Yield

-2.44%

NTRA Fundamentals

NTRA Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

43.2%

Rev. Growth (Qtr)

15.95%

NTRA Earnings

Earnings (TTM)

-434.8M

Earnings Growth (Yr)

45.27%

Earnings Growth (Qtr)

28.43%

Breaking Down NTRA Revenue

52 Week Range

42.3297.55

(Low)(High)

Last 7 days

4.7%

Last 30 days

0.5%

Last 90 days

39.0%

Trailing 12 Months

83.1%

How does NTRA drawdown profile look like?

NTRA Financial Health

Current Ratio

4.1

NTRA Investor Care

Shares Dilution (1Y)

6.60%

Diluted EPS (TTM)

-3.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	867.8M	931.0M	988.7M	1.1B
2022	667.3M	723.5M	776.0M	820.2M
2021	449.3M	504.9M	564.8M	625.5M
2020	329.5M	341.6M	361.9M	391.0M
2019	262.1M	273.4M	286.1M	302.3M
2018	222.6M	233.4M	242.7M	257.7M
2017	204.6M	204.9M	206.9M	209.6M
2016	204.8M	211.7M	220.7M	217.1M
2015	179.4M	188.7M	187.3M	190.4M
2014	81.2M	107.2M	133.3M	159.3M
2013	0	0	0	55.2M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Natera Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	brophy michael burkes	sold	-175,344	93.9676	-1,866	chief financial officer
Apr 29, 2024	chapman steven leonard	sold	-380,378	93.1387	-4,084	ceo and president
Apr 29, 2024	brophy michael burkes	sold	-115,306	93.1387	-1,238	chief financial officer
Apr 29, 2024	moshkevich solomon	sold	-111,394	93.1387	-1,196	president, clinicaldiagnostics
Apr 29, 2024	rabinowitz daniel	sold	-98,447	93.1387	-1,057	sec. and chief legal officer
Apr 29, 2024	fesko john	sold	-86,525	93.1387	-929	president, chief bus. officer
Apr 26, 2024	brophy michael burkes	sold	-69,092	92.00	-751	chief financial officer
Apr 26, 2024	rosenman herm	acquired	-	-	732	-

Which funds bought or sold NTRA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	TEACHER RETIREMENT SYSTEM OF TEXAS	added	83.84	1,773,000	2,826,000	0.02%
May 06, 2024	SG Americas Securities, LLC	reduced	-61.29	-395,000	512,000	-%
May 06, 2024	BANQUE PICTET & CIE SA	reduced	-8.72	2,676,730	10,719,000	0.10%
May 06, 2024	HighTower Advisors, LLC	added	8.47	567,000	1,539,000	-%
May 06, 2024	Manchester Capital Management LLC	unchanged	-	115	366	-%
May 06, 2024	Advisory Services Network, LLC	sold off	-100	-65,960	-	-%
May 06, 2024	Savant Capital, LLC	new	-	588,363	588,363	0.01%
May 06, 2024	Envestnet Portfolio Solutions, Inc.	added	19.2	352,001	827,439	-%
May 06, 2024	Parallel Advisors, LLC	added	34.21	34,262	69,967	-%
May 06, 2024	Quantbot Technologies LP	new	-	163,713	163,713	0.01%

Are Funds Buying or Selling NTRA?

Are funds buying NTRA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NTRA

No. of Funds

NTRA Alerts

4 major insider sales recently.

Unveiling Natera Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	alger associates inc	5.9%	7,076,157	SC 13G/A
Feb 13, 2024	vanguard group inc	9.13%	10,971,895	SC 13G/A
Jan 31, 2024	blackrock inc.	5.2%	6,305,838	SC 13G
Jan 23, 2024	jpmorgan chase & co	6.6%	7,964,473	SC 13G/A
Apr 06, 2023	blackrock inc.	4.9%	5,509,188	SC 13G/A
Feb 14, 2023	alger associates inc	8.2%	8,972,721	SC 13G/A
Feb 09, 2023	vanguard group inc	9.01%	9,945,514	SC 13G/A
Feb 03, 2023	blackrock inc.	5.1%	5,566,743	SC 13G
Jan 23, 2023	jpmorgan chase & co	5.6%	6,211,632	SC 13G/A
Jun 09, 2022	blackrock inc.	4.9%	4,706,415	SC 13G

Recent SEC filings of Natera Inc

View All Filings

Date Filed	Form Type	Document
May 03, 2024	4	Insider Trading
May 01, 2024	144	Notice of Insider Sale Intent
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading

Peers (Alternatives to Natera Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	184.3B	23.7B	1.86%	4.00%	41.87	7.76	-8.94%	-35.91%
A	41.4B	6.7B	-1.98%	6.66%	33.5	6.15	-2.81%	-6.58%
IDXX	40.0B	3.7B	-6.80%	-0.27%	46.15	10.74	8.57%	23.94%
DGX	15.2B	9.3B	4.84%	1.65%	17.98	1.64	-3.29%	6.68%
MEDP	12.5B	2.0B	0.34%	91.91%	39.87	6.35	25.57%	21.62%
CRL	12.1B	4.1B	-6.65%	24.43%	25.56	2.94	3.86%	-2.39%
NTRA	11.7B	1.1B	0.49%	83.09%	-27	10.84	31.99%	20.63%
EXAS	11.1B	2.5B	-12.56%	-10.42%	-54.61	4.46	19.93%	67.26%
MID-CAP
NEOG	2.7B	929.2M	-13.59%	-27.74%	1.7K	2.89	28.93%	111.61%
GH	2.3B	563.9M	6.75%	-20.02%	-4.78	4.06	25.45%	26.76%
SMALL-CAP
CDNA	542.6M	280.3M	8.83%	27.65%	-2.85	1.94	-12.89%	-148.37%
ACRS	95.5M	31.1M	14.29%	-83.81%	-1.24	3.07	0.95%	19.75%
APDN	61.1M	9.0M	833.33%	253.40%	-8.46	6.79	-53.31%	2.21%
AWH	36.4M	9.2M	11.36%	-35.81%	-2.18	3.98	11.85%	44.15%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Natera Inc News

Latest updates

Natera Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	16.0%	311,105,000	268,306,000	261,404,000	241,756,000	217,252,000	210,637,000	198,200,000	194,133,000	173,028,000	158,116,000	142,026,000	152,316,000	112,378,000	98,143,000	86,472,000	94,012,000	83,240,000	77,909,000	74,355,000	66,824,000	66,965,000
Costs and Expenses	4.3%	395,641,000	379,288,000	373,830,000	380,057,000	359,025,000	329,689,000	341,285,000	331,263,000	312,694,000	308,313,000	257,320,000	215,333,000	186,346,000	153,920,000	138,132,000	128,884,000	118,051,000	99,003,000	102,991,000	98,570,000	96,692,000
S&GA Expenses	4.3%	161,430,000	154,742,000	152,508,000	149,627,000	143,822,000	147,667,000	149,468,000	147,634,000	146,761,000	128,485,000	127,456,000	108,332,000	94,080,000	75,678,000	68,188,000	65,681,000	58,587,000	56,715,000	47,042,000	43,832,000	41,133,000
R&D Expenses	7.4%	82,964,000	77,235,000	78,173,000	82,306,000	87,911,000	65,510,000	82,580,000	80,414,000	71,811,000	98,457,000	53,752,000	40,188,000	32,384,000	26,421,000	23,005,000	18,225,000	15,002,000	12,796,000	12,124,000	11,435,000	12,770,000
EBITDA Margin	22.0%	-0.37	-0.47	-0.52	-0.59	-0.63	-0.67	-0.76	-0.79	-0.72	-0.68	-0.58	-0.52	-	-	-	-	-	-	-	-	-
Interest Expenses	-3.2%	3,148,000	3,252,000	3,177,000	3,061,000	2,752,000	2,330,000	2,150,000	2,087,000	2,079,000	2,078,000	2,075,000	2,073,000	4,310,000	4,270,000	4,038,000	2,464,000	2,576,000	2,672,000	2,721,000	2,724,000	2,746,000
Income Taxes	-5.4%	191,000	202,000	-282,000	160,000	421,000	185,000	193,000	179,000	-30,000	272,000	242,000	134,000	35,000	25,000	15,000	23,000	-14,000	44,000	1,895,000	74,000	-14,000
Earnings Before Taxes	28.5%	-77,840,000	-108,828,000	-111,085,000	-136,777,000	-142,152,000	-121,295,000	-144,958,000	-138,416,000	-140,594,000	-151,001,000	-115,784,000	-63,719,000	-76,376,500	-58,298,000	-59,622,000	-35,349,000	-35,197,000	-23,093,000	-30,521,000	-34,017,000	-31,855,000
EBT Margin	20.4%	-0.40	-0.50	-0.55	-0.63	-0.67	-0.70	-0.79	-0.82	-0.75	-0.72	-0.62	-0.57	-	-	-	-	-	-	-	-	-
Net Income	28.4%	-78,031,000	-109,030,000	-110,803,000	-136,937,000	-142,573,000	-121,480,000	-145,151,000	-138,595,000	-140,564,000	-151,273,000	-116,026,000	-63,853,000	-76,411,500	-58,323,000	-59,637,000	-35,372,000	-35,183,000	-23,137,000	-32,416,000	-34,091,000	-31,841,000
Net Income Margin	20.5%	-0.40	-0.51	-0.55	-0.63	-0.67	-0.70	-0.80	-0.82	-0.75	-0.72	-0.62	-0.57	-	-	-	-	-	-	-	-	-
Free Cashflow	-75.0%	-67,657,000	-38,656,000	-87,353,000	-92,488,000	-92,954,000	-114,457,000	-118,625,000	-153,162,000	-107,739,000	-104,197,000	-79,194,000	-85,136,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.3%	1,442	1,447	1,248	1,319	1,394	1,009	1,067	1,145	1,236	1,311	850	894	932	977	723	559	583	380	383	261	268
Current Assets	-0.7%	1,259	1,267	1,066	1,129	1,212	830	902	980	1,093	1,191	740	791	863	916	664	497	523	324	322	208	241
Cash Equivalents	-4.0%	642	669	381	403	466	57.00	91.00	159	85.00	95.00	63.00	65.00	49.00	210	77.00	74.00	62.00	52.00	30.00	35.00	51.00
Inventory	-3.1%	41.00	42.00	43.00	41.00	35.00	40.00	30.00	25.00	27.00	28.00	28.00	24.00	20.00	20.00	18.00	14.00	12.00	13.00	15.00	14.00	14.00
Net PPE	6.1%	111	105	103	101	92.00	87.00	82.00	78.00	66.00	59.00	49.00	40.00	33.00	28.00	26.00	27.00	23.00	19.00	22.00	23.00	24.00
Liabilities	2.2%	676	662	652	668	689	647	622	602	583	552	551	521	446	441	419	300	304	296	290	256	236
Current Liabilities	6.0%	307	290	277	291	310	267	252	231	219	200	198	167	199	196	176	177	180	138	127	113	114
Short Term Borrowings	0.0%	80.00	80.00	80.00	80.00	80.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00
Shareholder's Equity	-2.5%	765	785	596	651	706	362	445	542	653	759	299	372	486	536	304	259	279	85.00	93.00	5.00	32.00
Retained Earnings	-4.4%	-2,400	-2,299	-2,190	-2,100	-1,942	-1,800	-1,678	-1,533	-1,394	-1,254	-1,103	-987	-929	-852	-794	-734	-699	-663	-640	-699	-574
Additional Paid-In Capital	1.8%	3,146	3,089	2,796	2,742	2,665	2,181	2,140	2,090	2,050	2,012	1,400	1,356	1,411	1,384	1,093	988	977	748	733	614	607
Shares Outstanding	0.5%	120	119	114	113	111	97.00	96.00	96.00	91.00	89.00	88.00	87.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	5,260	-	-	-	2,570	-	-	-	9,330	-	-	-	3,510	-	-	-	1,550	-	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-96.7%	-58.12	-29.55	-78.39	-80.89	-81.13	-102	-110	-137	-98.74	-91.06	-70.56	-74.88	-73.30	-33.13	-40.98	-35.10	19.00	-48.39	-35.75	-31.82	-12.81
Share Based Compensation	-15.3%	49.00	58.00	44.00	41.00	36.00	40.00	41.00	35.00	30.00	26.00	35.00	23.00	16.00	15.00	12.00	7.00	2.00	20.00	10.00	4.00	4.00
Cashflow From Investing	-69.6%	25.00	81.00	47.00	16.00	22.00	67.00	35.00	207	80.00	-431	60.00	87.00	-99.17	-110	-165	43.00	-151	-71.11	-100	13.00	22.00
Cashflow From Financing	-97.1%	7.00	236	9.00	2.00	468	1.00	9.00	4.00	9.00	555	8.00	5.00	12.00	276	210	4.00	161	120	116	3.00	3.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NTRA Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues
Total revenues	$ 1,082,571	$ 820,222	$ 625,486
Cost and expenses
Research and development	320,678	316,415	264,208
Selling, general and administrative	618,307	588,591	511,034
Total cost and expenses	1,528,816	1,361,262	1,093,660
Loss from operations	(446,245)	(541,040)	(468,174)
Interest expense	(12,638)	(9,319)	(8,305)
Interest and other income, net	24,353	3,538	5,381
Loss before income taxes	(434,530)	(546,821)	(471,098)
Income tax expense	(271)	(978)	(618)
Net loss	(434,801)	(547,799)	(471,716)
Unrealized gain (loss) on available-for-sale securities, net of tax	13,277	(14,075)	(6,546)
Comprehensive loss	$ (421,524)	$ (561,874)	$ (478,262)
Net Loss per Share
Basic (in dollars per share)	$ (3.78)	$ (5.57)	$ (5.21)
Diluted (in dollars per share)	$ (3.78)	$ (5.57)	$ (5.21)
Weighted-average number of shares used in computing basic and diluted net loss per share:
Basic (in shares)	114,997	98,408	90,558
Diluted (in shares)	114,997	98,408	90,558
Product
Revenues
Total revenues	$ 1,068,522	$ 797,307	$ 580,080
Cost and expenses
Cost of revenues	588,564	453,632	315,195
Licensing and other
Revenues
Total revenues	14,049	22,915	45,406
Cost and expenses
Cost of revenues	$ 1,267	$ 2,624	$ 3,223

NTRA Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash, cash equivalents and restricted cash	$ 642,095	$ 466,091
Short-term investments	236,882	432,301
Accounts receivable, net of allowance of $6,481 in 2023 and $3,830 in 2022	278,289	244,385
Inventory	40,759	35,406
Prepaid expenses and other current assets, net	60,524	33,634
Total current assets	1,258,549	1,211,817
Property and equipment, net	111,210	92,453
Operating lease right-of-use assets	56,537	71,874
Other assets	15,403	18,330
Total assets	1,441,699	1,394,474
Current liabilities:
Accounts payable	14,998	31,148
Accrued compensation	45,857	44,010
Other accrued liabilities	149,405	144,214
Deferred revenue, current portion	16,612	10,777
Short-term debt financing	80,402	80,350
Total current liabilities	307,274	310,499
Long-term debt financing	282,945	281,653
Deferred revenue, long-term portion	19,128	20,001
Operating lease liabilities, long-term portion	67,025	76,577
Total liabilities	676,372	688,730
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both December 31, 2023 and 2022; 119,581 and 111,255 shares issued and outstanding at December 31, 2023 and 2022, respectively	11	11
Additional paid in capital	3,145,837	2,664,730
Accumulated deficit	(2,377,436)	(1,942,635)
Accumulated other comprehensive loss	(3,085)	(16,362)
Total stockholders' equity	765,327	705,744
Total liabilities and stockholders' equity	$ 1,441,699	$ 1,394,474

About Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company's products also comprise Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

CEO	Mr. Steven Leonard Chapman
WEBSITE	natera.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	2958

Natera Inc Frequently Asked Questions

What is the ticker symbol for Natera Inc? What does NTRA stand for in stocks?

NTRA is the stock ticker symbol of Natera Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Natera Inc (NTRA)?

As of Tue May 07 2024, market cap of Natera Inc is 11.74 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NTRA stock?

You can check NTRA's fair value in chart for subscribers.

What is the fair value of NTRA stock?

You can check NTRA's fair value in chart for subscribers. The fair value of Natera Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Natera Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NTRA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Natera Inc a good stock to buy?

The fair value guage provides a quick view whether NTRA is over valued or under valued. Whether Natera Inc is cheap or expensive depends on the assumptions which impact Natera Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NTRA.

What is Natera Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, NTRA's PE ratio (Price to Earnings) is -27 and Price to Sales (PS) ratio is 10.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NTRA PE ratio will change depending on the future growth rate expectations of investors.